Roche receives CE approval for Elecsys ApoE4 biomarker test
Source: SeekingAlpha
2026-03-16 02:41:02 ET
More on Roche Holding
- Roche Holding AG (RHHBY) Discusses Phase III Study Results and Updates on Immunology Kidney Pipeline - Slideshow
- Roche Falters In A Key Breast Cancer Readout
- Roche Holding AG (RHHBY) Discusses Phase III Study Results and Updates on Immunology Kidney Pipeline Transcript
- Roche stock falls after breast cancer combo therapy fails in trial
- Roche continues to expect tariff impact on diagnostics despite U.S. deal
Read the full article on Seeking Alpha
For further details see:
Roche receives CE approval for Elecsys ApoE4 biomarker test
Roche Holding Ltd
NASDAQ: RHHBF
RHHBF Trading
-0.7% G/L:
$384.03 Last:
8 Volume:
$384.03 Open:
RHHBF Latest News
RHHBF Stock Data
$362,551,633,888
800,578,845
N/A
474
N/A
Pharmaceuticals
Healthcare
CH
Basel Switzerland
